JPMorgan Chase has extended its JPM Coin deposit token to the Ethereum network, allowing institutional clients to use the bank-backed digital dollar on a major public blockchain. This move builds on its prior launch on Coinbase's Base network and enables near-instant, 24/7 peer-to-peer transfers and settlements, bypassing traditional banking delays. JPM Coin remains a permissioned token for JPMorgan's institutional clients, ensuring regulatory compliance and maintaining funds within the bank's infrastructure. This expansion enhances liquidity and efficiency for institutional users operating within the Ethereum ecosystem, reflecting a broader trend of integrating regulated bank money with public blockchain technology.
JPMorgan's expansion of the JPM Coin deposit token to the Ethereum network provides context for cryptocurrency market activity. For readers following crypto assets, here is Pluang's market snapshot as of Oct 19, 2026 20:22 WIB: out of 50 major cryptocurrencies priced on Pluang, 31 rose and 18 fell today. Notable movers include BAL (Balancer) at Rp16.297 with an 11.14% increase, EOS (EOS.IO) at Rp12.649 up 8.13%, and ATOM (Cosmos) at Rp31.673 rising 5.34% with a strong buy order activity of 77%.
Disc Medicine's stock surged 38% following positive Phase 3 trial results for its drug bitopertin, which showed efficacy and safety in treating erythropoietic protoporphyria. BMO Capital raised its price target from $100 to $120 and maintained an Out...
Qualcomm executive Ann C. Chaplin sold 1,827 shares of the company's stock for $319,268.25 under a Rule 10b5-1 trading plan, reducing her holdings by 6.62%. Qualcomm's stock price recently traded below its 50-day and 200-day moving averages, signalin...
BOK Financial is set to announce its Q3 2026 earnings after market close on October 19, with analysts forecasting earnings per share between $2.52 and $2.54 and revenue near $571 million. The company has a strong history of surpassing earnings estima...
AIBotics has completed the acquisition of NovaCore Labs' assets from PlayJamaica Limited, gaining technology, software, drones, mapping equipment, and customer contracts. This move expands AIBotics' platform in Jamaica and the Caribbean, enhancing AI...
EyePoint's stock dropped sharply after its DURAVYU treatment did not meet the primary endpoint in a Phase 3 trial for wet age-related macular degeneration (wet AMD). Although DURAVYU showed some vision improvement and reduced the need for additional ...
